Evidence map›Paper›PMID 21804954›Full record

ArticleBasal ganglia2011

GPR88 - a putative signaling molecule predominantly expressed in the striatum: Cellular localization and developmental regulation.

Vincent Van Waes, Kuei Y Tseng, Heinz Steiner

Open access · greenAbstract read
In one paragraph

Article in Basal ganglia, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
1.2field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 51 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Vincent Van WaesDepartment of Cellular and Molecular Pharmacology, Rosalind Franklin University of Medicine and Science/The Chicago Medical School, North Chicago, IL 60064, USA.
Kuei Y Tseng
Heinz Steiner
Rosalind Franklin University of Medicine and Science · US

Funding

Monoaminergic regulation of prefrontal cortex inhibition during adolescenceR01MH086507 · NIMH · UNIVERSITY OF ILLINOIS AT CHICAGO · PI Kuei-Yuan Tseng · 2010 to 2026
$5.7M
BASAL GANGLIA OUTPUT AND PSYCHOSTIMULANT ABUSER01DA011261 · NIDA · ROSALIND FRANKLIN UNIV OF MEDICINE &SCI · PI STEINER, HEINZ · 2005 to 2009
$1.3M
OPIOID PEPTIDES AND COCAINE ABUSER29DA011261 · NIDA · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI STEINER, HEINZ · 1998 to 2002
$306k
NIDA NIH HHS R01 DA011261NIDA NIH HHS R29 DA011261NIMH NIH HHS R01 MH086507
6 · The paper itself

Abstract

GPR88 is a putative G-protein-coupled receptor that is highly and almost exclusively expressed in the striatum. Its function remains unknown. We investigated GPR88 cellular localization and expression levels across development in different functional domains of the striatum in juvenile (P25), adolescent (P40), and adult (P70) rats, by in situ hybridization histochemistry. At all ages, GPR88 mRNA expression was most robust in the sensorimotor (lateral) striatum and was detected in virtually every neuron. Expression was highest in juveniles and decreased thereafter with regionally distinct trajectories. Thus, in the dorsal striatum, there was a progressive decrease from juveniles to adolescents to adults. In contrast, in the nucleus accumbens, the only (modest) decrease occurred between juveniles and adolescents. These findings indicate that GPR88 is expressed in all striatal neurons, but is differentially regulated across development in different striatal regions.

Identifiers

PMID21804954
PMCPMC3144573
OpenAlexW2155014655

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.